Objective To provide a clinical framework and key guideline statements to assist clinicians
in the evidence‐based management of Peyronie’s disease (PD). Methods We conducted a …

… andrology and urology societies across Europe, with the … committee of the European Society
of Sexual Medicine. In the end… PD = Peyronie's disease. Figure 1 is available in color online …

… To review the evidence associated with surgical treatment of Peyronie‘s Disease and provide
clinical recommendations on behalf of the European Society for Sexual Medicine. 131 peer…

… Background: Despite the existence of conservative therapies for Peyronie’s disease (PD), …
Methods: Data were prospectively collected in 5 European academic centers between 2016 …

… We highlight consensus of major urologic societies on many aspects of work up and … To
address the known short-comings and enhance patient care, several medical societies have …

… The aim of the present paper is to provide a detailed position statement of the European
Society for Sexual Medicine (ESSM) on this topic, summarizing and emphasizing the current …

… , anatomists, and pathologists had already described Peyronie's disease some centuries
before the author after whom it has been called, François Gigot de La Peyronie (1678–1747). …

… Peyronie's disease (PD) is a progressive fibrotic disorder … The distinctive characteristic of
the disease is the development … disease was fully described by Francois Gigot de la Peyronie, …

Peyronie’s disease (PD) is a superficial fibrosing disorder of the penis resulting in plaque
formation and penile deformity. Once considered rare, PD has more recently been found in up …

… Peyronie's disease (PD) is characterized by a constellation of penile symptoms and signs
such … graft material use among surgeons in various sexual medicine societies. APSSM = Asia …